Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Life Sciences : CMLS|March 31, 2021
The role of heme oxygenase-1 in hematopoietic system and its microenvironmentAgata Szade, Krzysztof Szade, Mahdi Mahdi, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 19, 2020
Bioactive Salen-type Schiff Base Transition Metal Complexes as Possible Anticancer AgentsMaryam Damercheli, Mahdi Mahdi, Bita Mehravi, et al.
JMIR Research Protocols|June 23, 2023
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)Imran Howell, Mahdi Mahdi, Mona Bafadhel, et al.
The Lancet. Respiratory Medicine|April 10, 2022
Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysisJonathan R Baker, Mahdi Mahdi, Dan V Nicolau, et al.
The Lancet. Respiratory Medicine|November 30, 2024
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trialSanjay Ramakrishnan, Richard E K Russell, Hafiz R Mahmood, et al.
ERJ Open Research|May 15, 2024
Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19Steven P Cass, Dan V Nicolau, Jonathan R Baker, et al.
The Lancet. Respiratory Medicine|November 4, 2023
Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trialSanjay Ramakrishnan, Helen Jeffers, Beverly Langford-Wiley, et al.
The Lancet. Respiratory Medicine|April 12, 2021
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trialSanjay Ramakrishnan, Dan V Nicolau, Beverly Langford, et al.
Pageof 1